anmeldenFTSE All-Share
5.814,48
PKT
-27,89
PKT
-0,48
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu FTSE All-Share-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 05.05.15 | Lloyds Banking Group buy | Société Générale Group S.A. (SG) | |
| 05.05.15 | GSK overweight | Barclays Capital | |
| 05.05.15 | Prudential overweight | Barclays Capital | |
| 04.05.15 | Lloyds Banking Group Halten | Independent Research GmbH | |
| 04.05.15 | Shell (ex Royal Dutch Shell) Neutral | UBS AG | |
| 04.05.15 | HSBC Conviction Buy List | Goldman Sachs Group Inc. | |
| 01.05.15 | Lloyds Banking Group Strong Buy | S&P Capital IQ | |
| 01.05.15 | GSK Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 01.05.15 | Shell (ex Royal Dutch Shell) Outperform | Credit Suisse Group | |
| 01.05.15 | Barclays Sell | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 30.04.15 | Shell (ex Royal Dutch Shell) Hold | S&P Capital IQ | |
| 30.04.15 | Standard Chartered verkaufen | Deutsche Bank AG | |
| 30.04.15 | Prudential Neutral | JP Morgan Chase & Co. | |
| 30.04.15 | Barclays buy | Deutsche Bank AG | |
| 30.04.15 | Standard Chartered neutral | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 30.04.15 | Barclays overweight | JP Morgan Chase & Co. | |
| 30.04.15 | GSK buy | UBS AG | |
| 29.04.15 | BP Neutral | Goldman Sachs Group Inc. | |
| 29.04.15 | Sky Neutral | JP Morgan Chase & Co. | |
| 29.04.15 | BP Underweight | JP Morgan Chase & Co. | |
| 29.04.15 | AstraZeneca buy | Merrill Lynch & Co., Inc. | |
| 29.04.15 | BP Hold | Société Générale Group S.A. (SG) | |
| 29.04.15 | Glencore Neutral | Citigroup Corp. | |
| 29.04.15 | Rio Tinto Neutral | Citigroup Corp. | |
| 29.04.15 | BP Verkaufen | Independent Research GmbH | |
| 29.04.15 | BAT Hold | S&P Capital IQ | |
| 29.04.15 | AstraZeneca buy | Citigroup Corp. | |
| 29.04.15 | Barclays buy | Deutsche Bank AG | |
| 29.04.15 | Standard Chartered Neutral | Nomura | |
| 29.04.15 | BP Neutral | UBS AG | |
| 29.04.15 | GSK buy | UBS AG | |
| 29.04.15 | Standard Chartered Neutral | UBS AG | |
| 29.04.15 | Vodafone Group buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 28.04.15 | BP Sell | S&P Capital IQ | |
| 28.04.15 | HSBC Equal-Weight | Morgan Stanley | |
| 28.04.15 | Standard Chartered Hold | S&P Capital IQ | |
| 28.04.15 | AstraZeneca buy | UBS AG | |
| 28.04.15 | GSK buy | Goldman Sachs Group Inc. | |
| 27.04.15 | Prudential buy | Jefferies & Company Inc. | |
| 27.04.15 | AstraZeneca Neutral | Goldman Sachs Group Inc. |
